Wordt geladen...
Locoregional therapy in hepatocellular carcinoma: when to start and when to stop and when to revisit
With increasing therapeutic options available for advanced hepatocellular carcinoma (HCC), the timing and sequencing of locoregional and systemic therapy need to be re-examined. This is especially so for patients with intermediate HCC, so as to optimize responses while preserving liver reserves, and...
Bewaard in:
| Gepubliceerd in: | ESMO Open |
|---|---|
| Hoofdauteurs: | , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Elsevier
2021
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8086015/ https://ncbi.nlm.nih.gov/pubmed/33887687 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.esmoop.2021.100129 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|